Evidence map›Paper›PMID 35929723›Full record

ArticleeLife2022

An auto-inhibited state of protein kinase G and implications for selective activation.

Rajesh Sharma, Jeong Joo Kim, Liying Qin, Philipp Henning, Madoka Akimoto, Bryan VanSchouwen, Gundeep Kaur, Banumathi Sankaran, Kevin R MacKenzie, Giuseppe Melacini and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. The Human PNPLA3FASEB bioAdvances · 2026
    Article
  3. Article
  4. Review
  5. Dietary Beetroot Juice - Effects in Patients with COPD: A Review.International journal of chronic obstructive pulmonary disease · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Rajesh SharmaDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.
Jeong Joo KimDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.
Liying QinDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.
Philipp HenningDepartment of Biochemistry, University of Kassel, Kassel, Germany.
Madoka AkimotoDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Canada.
Bryan VanSchouwenDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Canada.
Gundeep KaurDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.
Banumathi SankaranMolecular Biophysics and Integrated Bioimaging, Berkeley, United States.
Kevin R MacKenzieDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.ORCID 0000-0001-9620-5868
Giuseppe MelaciniDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Canada.
Darren E CasteelDepartment of Medicine, University of California, San Diego, San Diego, United States.ORCID 0000-0002-7673-6597
Friedrich W HerbergDepartment of Biochemistry, University of Kassel, Kassel, Germany.
Choel KimDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine, Houston, United States.ORCID 0000-0002-3152-0020
Baylor College of Medicine · USMcMaster University · CAUniversity of Kassel · DEUniversity of California San Diego · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
Targeting mechanisms of cGMP dependent protein kinases by peptide arrays and crysR01GM090161 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI KIM, CHOEL WOONG · 2010 to 2018
$2.9M
A Pixel Array Detector System for Small Angle X-ray ScatteringS10OD018483 · OD · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CLASSEN, SCOTT · 2014 to 2014
$998k
Protein Crystallization ImagerS10OD030246 · OD · BAYLOR COLLEGE OF MEDICINE · PI LEE, SUKYEONG · 2021 to 2021
$136k
CIHR 389522NIGMS NIH HHS P30 GM124169NIGMS NIH HHS R01 GM090161NIH HHS S10 OD018483NIH HHS S10 OD030246
6 · The paper itself

Abstract

Cyclic GMP-dependent protein kinases (PKGs) are key mediators of the nitric oxide/cyclic guanosine monophosphate (cGMP) signaling pathway that regulates biological functions as diverse as smooth muscle contraction, cardiac function, and axon guidance. Understanding how cGMP differentially triggers mammalian PKG isoforms could lead to new therapeutics that inhibit or activate PKGs, complementing drugs that target nitric oxide synthases and cyclic nucleotide phosphodiesterases in this signaling axis. Alternate splicing of PRKG1 transcripts confers distinct leucine zippers, linkers, and auto-inhibitory (AI) pseudo-substrate sequences to PKG Iα and Iβ that result in isoform-specific activation properties, but the mechanism of enzyme auto-inhibition and its alleviation by cGMP is not well understood. Here, we present a crystal structure of PKG Iβ in which the AI sequence and the cyclic nucleotide-binding (CNB) domains are bound to the catalytic domain, providing a snapshot of the auto-inhibited state. Specific contacts between the PKG Iβ AI sequence and the enzyme active site help explain isoform-specific activation constants and the effects of phosphorylation in the linker. We also present a crystal structure of a PKG I CNB domain with an activating mutation linked to Thoracic Aortic Aneurysms and Dissections. Similarity of this structure to wildtype cGMP-bound domains and differences with the auto-inhibited enzyme provide a mechanistic basis for constitutive activation. We show that PKG Iβ auto-inhibition is mediated by contacts within each monomer of the native full-length dimeric protein, and using the available structural and biochemical data we develop a model for the regulation and cooperative activation of PKGs.

Indexed as

Cyclic GMP-Dependent Protein Kinase Type INitric OxideAnimalsCyclic GMPMammalsPhosphorylationProtein IsoformsCyclic GMPCyclic GMP-Dependent Protein Kinase Type INitric OxideProtein IsoformsbiochemistrycGMP signalingchemical biologyhumankinase activationkinase regulationmammalian signal transductionmolecular biophysicsprotein–protein complexsecond messengerstructural biologyTAAD

Identifiers

PMID35929723
PMCPMC9417419
OpenAlexW4289886698

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.